Stock Trend Analysis Report
Prepared for you on Sunday, August 14, 2022.
PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS)
Countertrend Up (+85) - PHAS is showing short-term weakness. However, look for the longer-term bullish trend to resume. As always, continue to monitor the trend score and utilize a stop order.
Is it time to buy, sell, or avoid PHAS?
MarketClub looks at technical strength and momentum to determine if the timing is right for PHAS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for PHAS
The long-term trend has been UP since Aug 3rd, 2022 at 1.3199
The intermediate-term trend has been UP since Jul 6th, 2022 at 0.7567
The short-term trend has been DOWN since Aug 10th, 2022 at 1.2000
Smart Scan Analysis for PHAS
Based on our trend formula, PHAS is rated as a +85 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||6||Year High Date||2018-10-31|
|Year Low||2.55||Year Low Date||2018-11-20|
|52wk High||4.1||52wk High Date||2021-10-14|
|52wk Low||0.4999||52wk Low Date||2022-06-16|
|Average Volume||206,623||Shares Outstanding||48,691|